AI assistant
Sending…
Mirum Pharmaceuticals, Inc. — Director's Dealing 2021
Aug 20, 2021
31228_dirs_2021-08-20_7cb894a4-db23-43e0-9d78-4af795540f6a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Mirum Pharmaceuticals, Inc. (MIRM)
CIK: 0001759425
Period of Report: 2021-08-19
Reporting Person: Fairey William (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-19 | Stock Option (right to buy) | $14.19 | A | 34000 | Acquired | 2031-08-18 | Common Stock (34000) | Direct |
Footnotes
F1: The shares vest in equal annual installments over a three year period such that the option is fully vested on the third anniversary of the date of grant.
More from Mirum Pharmaceuticals, Inc.
Capital/Financing Update
2026
May 18
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 27
Annual Report
2026
Apr 24
M&A Activity
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18